Cargando…
What is the efficacy of BCG vaccination in the protection from COVID-19 in European countries?
Autores principales: | Ghazvini, K., Keikha, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413156/ http://dx.doi.org/10.1016/j.phclin.2020.08.001 |
Ejemplares similares
-
What are the clinical benefits of tocilizumab for COVID-19 patients? Evidence from available case-control studies
por: Ghazvini, Kiarash, et al.
Publicado: (2021) -
Virological cure, clinical efficacy and safety of Remdesivir supplementation against SARS-CoV 2 infection; evidence from human studies
por: Ghazvini, K., et al.
Publicado: (2021) -
Multivalent vaccines against new SARS-CoV-2 hybrid variants
por: Ghazvini, Kiarash, et al.
Publicado: (2023) -
COVID-19 Death and BCG Vaccination
por: Wiwanitkit, Viroj
Publicado: (2021) -
BCG Protection Against COVID-19: Is it Reality or Illusion?
por: Sharqule, Inas K., et al.
Publicado: (2021)